Loading...

WuXi Biologics (Cayman) Inc.

WXXWYPNK
Healthcare
Biotechnology
$8.55
$0.41(5.04%)

WuXi Biologics (Cayman) Inc. (WXXWY) Stock Competitors & Peer Comparison

See (WXXWY) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
WXXWY$8.55+5.04%17.4B31.63$0.27N/A
NONOF$57.10+1.96%253.7B14.68$3.89+3.03%
CSLLY$70.42-2.37%136.3B22.78$3.09+1.88%
CMXHF$148.15-1.77%71.7B24.01$6.17+1.87%
UCBJF$235.70+0.74%45.3B29.89$7.98+0.66%
UCBJY$115.94+0.65%44B28.92$4.00+0.68%
ARGNF$619.44+0.00%37.9B31.54$19.64N/A
ODTC$22,005.00+29.44%24.1B1.07$20,580.00N/A
IVBXF$12.73+0.24%21.8B-1273.00-$0.01N/A
SBMFF$0.99+0.00%17.7B32.97$0.03+0.90%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

WXXWY vs NONOF Comparison August 2025

WXXWY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, WXXWY stands at 17.4B. In comparison, NONOF has a market cap of 253.7B. Regarding current trading prices, WXXWY is priced at $8.55, while NONOF trades at $57.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

WXXWY currently has a P/E ratio of 31.63, whereas NONOF's P/E ratio is 14.68. In terms of profitability, WXXWY's ROE is +0.08%, compared to NONOF's ROE of +0.78%. Regarding short-term risk, WXXWY is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for WXXWY.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;